Clinical Trial: Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients

Brief Summary: This study evaluates the efficacy of erythropoietin in refractory autoimmune encephalitis. Ten patients will receive 100 IU/kg of erythropoietin 3 times a week for 12 weeks.